Lamberto Andreotti
CIK 1208099 · Chief Executive Officer · last filed 2025-05-02
Lamberto Andreotti is a Chief Executive Officer who has filed 131 SEC Form 4 insider transactions across 5 companies since 2007. The most recent filing, for CTVA, was dated May 2, 2025. Across all open-market trades the lifetime net is −$101.4M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $74.4M across reported positions. 93 SEC filings were submitted jointly with BRISTOL MYERS SQUIBB CO.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
BMY price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
345 PARK AVENUE
NEW YORK, NY 10154
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CTVA | Director | 37,784 | $12.55 | $474.2K | -$2.6K | 8 | 2025-05-02 |
| DD | Director | 17,711 | $134.54 | $2.38M | $8.6K | 27 | 2019-06-26 |
| DuPont de Nemours, Inc. (DWDP) Delisted | Director | 21,655 | — | — | $0 | 7 | 2018-09-18 |
| BMY | Director | 1,152,571 | $62.11 | $71.59M | -$101.58M | 87 | 2017-04-10 |
| Mead Johnson Nutrition Co (MJN) Delisted | Director | 19,609 | — | — | $144.0K | 2 | 2009-12-28 |
Recent Filings
131 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-05-02 | CTVA | Grant (A) | +2,990 | $0 | EDGAR |
| 2024-04-30 | CTVA | Grant (A) | +3,100 | $0 | EDGAR |
| 2023-04-25 | CTVA | Grant (A) | +2,770 | $0 | EDGAR |
| 2022-05-03 | CTVA | Grant (A) | +2,950 | $0 | EDGAR |
| 2021-05-11 | CTVA | Grant (A) | +3,480 | $170.0K | EDGAR |
| 2020-04-30 | CTVA | Grant (A) | +6,500 | $170.2K | EDGAR |
| 2020-02-05 | CTVA | Sell (S) | −90 | -$2.6K | EDGAR |
| 2019-06-26 | DD | Mixed | +270 | $8.6K | EDGAR |
| 2019-06-05 | CTVA | Grant (A) | +6,860 | $0 | EDGAR |
| 2018-09-18 | DuPont de Nemours, Inc. (DWDP) Delisted | Grant (A) | +119 | $7.8K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.